Background To determine the kinetics and persistence of immune responses following the
Sinopharm/BBIBP‐CorV, we investigated immune responses in a cohort of Sri Lankan …

Background As there are limited data of the immunogenicity of the Sinopharm/BBIBP-CorV
in different populations, antibody responses against different SARS-CoV-2 variants of …

Background To determine the kinetics and persistence of immune responses following the
Sinopharm/BBIBP-CorV, we investigated immune responses in a cohort of Sri Lankan …

To determine the antibody responses elicited by different vaccines against SARS‐CoV‐2, we
compared antibody responses in individuals 3 months post‐vaccination in those who had …

As there are limited data of the immunogenicity of the Sinopharm/BBIBP‐CorV in different
populations, antibody responses against different SARS‐CoV‐2 variants of concern and T cell …

Background: As the Municipality Council area in Colombo (CMC) experienced the highest
number of cases until the end of January 2021, in Sri Lanka, we carried out a serosurvey prior …

As there are limited data on B-cell epitopes for the nucleocapsid protein in SARS-CoV-2, we
sought to identify the immunodominant regions within the N protein, recognized by patients …

Background To understand the kinetics of immune responses with different dosing gaps of
the AZD1222 vaccine, we compared antibody and T cell responses in two cohorts with two …

Several COVID-19 vaccines have received emergency approval. Here we assess the
immunogenicity of a single dose of the AZD1222 vaccine, at one month, in a cohort of health care …

The kinetics and magnitude of antibody responses to different proteins of the SARS-CoV-2
virus in Sinopharm/BBIBP-CorV vaccinees has not been previously studied. Therefore, we …